Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma - PubMed (original) (raw)
Review
Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma
J M Robertson et al. Cancer. 1996.
Abstract
The use of radiation therapy combined with 5-fluorouracil (5-FU) in the treatment of pancreatic cancer has been well established. It has been hypothesized that any benefit from combined 5-FU and radiation has been due to radiosensitization. Improved therapy could result from a better understanding of the mechanism of radiosensitization and the development of compounds capable of providing better radiosensitization. This article reviews preclinical findings on the mechanism of cytotoxicity and radiosensitization for 5-FU, fluorodeoxyuridine, thymidine analogs, and gemcitabine (2',2'-difluorodeoxycytidine) and discusses the clinical implications of these findings.
Similar articles
- On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
McGinn CJ, Lawrence TS, Zalupski MM. McGinn CJ, et al. Cancer. 2002 Aug 15;95(4 Suppl):933-40. doi: 10.1002/cncr.10754. Cancer. 2002. PMID: 12209674 Review. - [Concurrent chemoradiotherapy using full-dose gemcitabine for patients with unresectable pancreatic cancer].
Yamazaki H, Nishiyama K, Koizumi M. Yamazaki H, et al. Nihon Igaku Hoshasen Gakkai Zasshi. 2004 May;64(4):216-9. Nihon Igaku Hoshasen Gakkai Zasshi. 2004. PMID: 15211883 Japanese. - New applications of gemcitabine and future directions in the management of pancreatic cancer.
Abbruzzese JL. Abbruzzese JL. Cancer. 2002 Aug 15;95(4 Suppl):941-5. doi: 10.1002/cncr.10753. Cancer. 2002. PMID: 12209675 Review. - Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.
Crane CH, Wolff RA, Abbruzzese JL, Evans DB, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Lahoti S, Vauthey JN, Janjan NA. Crane CH, et al. Semin Oncol. 2001 Jun;28(3 Suppl 10):25-33. doi: 10.1053/sonc.2001.22536. Semin Oncol. 2001. PMID: 11510031 Review. - [Pancreatic cancer--diagnostics and therapy].
Schramm H. Schramm H. Zentralbl Chir. 2003 May;128(5):367. doi: 10.1055/s-2003-40028. Zentralbl Chir. 2003. PMID: 12813632 German. No abstract available.
Cited by
- [The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine].
Mose S, Karapetian M, Jüling-Pohlit L, Taborski B, Ramm U, Damrau M, Rahn A, Böttcher HD. Mose S, et al. Strahlenther Onkol. 1999 Feb;175(2):78-83. doi: 10.1007/BF02753847. Strahlenther Onkol. 1999. PMID: 10065143 German. - Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J. Klinkenbijl JH, et al. Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4. doi: 10.1097/00000658-199912000-00006. Ann Surg. 1999. PMID: 10615932 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical